SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 232 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $33,120 | -58.6% | 36,032 | -22.2% | 0.00% | – |
Q3 2022 | $80,000 | -39.4% | 46,292 | -68.3% | 0.00% | – |
Q2 2022 | $132,000 | +22.2% | 146,008 | +299.6% | 0.00% | – |
Q1 2022 | $108,000 | -24.5% | 36,538 | +22.7% | 0.00% | – |
Q4 2021 | $143,000 | -51.4% | 29,788 | -66.7% | 0.00% | -100.0% |
Q3 2021 | $294,000 | -3.0% | 89,443 | +13.3% | 0.00% | 0.0% |
Q2 2021 | $303,000 | -4.1% | 78,952 | +122.2% | 0.00% | 0.0% |
Q1 2021 | $316,000 | +47.0% | 35,537 | +26.6% | 0.00% | 0.0% |
Q4 2020 | $215,000 | +83.8% | 28,078 | +89.0% | 0.00% | 0.0% |
Q3 2020 | $117,000 | -14.6% | 14,853 | -44.7% | 0.00% | 0.0% |
Q2 2020 | $137,000 | +185.4% | 26,845 | -27.4% | 0.00% | – |
Q1 2020 | $48,000 | +20.0% | 36,977 | -11.9% | 0.00% | – |
Q4 2019 | $40,000 | -60.0% | 41,977 | +116.4% | 0.00% | -100.0% |
Q1 2018 | $100,000 | -20.0% | 19,398 | -38.9% | 0.00% | 0.0% |
Q1 2017 | $125,000 | -19.4% | 31,730 | 0.0% | 0.00% | -50.0% |
Q4 2016 | $155,000 | -32.0% | 31,730 | +7.8% | 0.00% | -33.3% |
Q3 2016 | $228,000 | – | 29,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
TRUST CO OF VERMONT | 204 | $19 | 0.00% |
SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |